0001213900-20-011419.txt : 20200508 0001213900-20-011419.hdr.sgml : 20200508 20200508144645 ACCESSION NUMBER: 0001213900-20-011419 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200427 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Natur International Corp. CENTRAL INDEX KEY: 0001552845 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 455547692 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54917 FILM NUMBER: 20860065 BUSINESS ADDRESS: STREET 1: PARNASSUS TOWER, LOCATELLIKADE 1 CITY: 1076 AZ AMSTERDAM STATE: P7 ZIP: 0000 BUSINESS PHONE: 011 31 20 578 7700 MAIL ADDRESS: STREET 1: PARNASSUS TOWER, LOCATELLIKADE 1 CITY: 1076 AZ AMSTERDAM STATE: P7 ZIP: 0000 FORMER COMPANY: FORMER CONFORMED NAME: Future Healthcare of America DATE OF NAME CHANGE: 20120621 8-K 1 ea121575-8k_naturinter.htm FORM 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 27, 2020

 

Natur International Corp.

(Exact name of registrant as specified in its charter)

 

Wyoming   000-54917   45-5547692

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

 

Parnassus Tower

Locatellikade 1

1076 AZ Amsterdam

The Netherlands

   
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +31 20 578 7700

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

Securities registered pursuant to Section 12(b) of the Act: 

 

 Title of each class   Trading Symbol(s)   Name on exchange on which registered
None   -   -

 

 

 

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.

On May 7, 2020, Mr. Spencer Chesman, the Chief Executive Officer of Natur International Corp. (“company”) resigned from the position of Chief Executive Officer. His resignation was for personal reasons. He remains a member of the board of directors.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Natur International Corp.  
   
Date:  May 8, 2020 By: /S/ Michael Jones
  Name:   Michael Jones
  Title: Director